Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction.

Standard

Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction. / Schumacher, G; Schmidt, S C; Schlechtweg, N; Rösch, Thomas; Sacchi, M; von Dossow, V; Chopra, S S; Pratschke, J; Zhukova, J; Stieler, J; Thuss-Patience, P; Neuhaus, P.

In: DIS ESOPHAGUS, Vol. 22, No. 5, 5, 2009, p. 422-426.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schumacher, G, Schmidt, SC, Schlechtweg, N, Rösch, T, Sacchi, M, von Dossow, V, Chopra, SS, Pratschke, J, Zhukova, J, Stieler, J, Thuss-Patience, P & Neuhaus, P 2009, 'Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction.', DIS ESOPHAGUS, vol. 22, no. 5, 5, pp. 422-426. <http://www.ncbi.nlm.nih.gov/pubmed/19191862?dopt=Citation>

APA

Schumacher, G., Schmidt, S. C., Schlechtweg, N., Rösch, T., Sacchi, M., von Dossow, V., Chopra, S. S., Pratschke, J., Zhukova, J., Stieler, J., Thuss-Patience, P., & Neuhaus, P. (2009). Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction. DIS ESOPHAGUS, 22(5), 422-426. [5]. http://www.ncbi.nlm.nih.gov/pubmed/19191862?dopt=Citation

Vancouver

Bibtex

@article{3a79577596b64ccbb48811417c261417,
title = "Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction.",
abstract = "Precise classification of cancers of the esophagogastric junction according to Siewert may be difficult for the presence of Barrett's esophagus or hiatal hernia, which subsequently leads to a difficult choice of the surgical procedure of esophagectomy or gastrectomy. Ninety-six patients with such cancers were operated on in our department in 7 years. Twenty-nine patients (30.2%), classified as type I (group 1), underwent a transthoracic esophagectomy with gastric pull up. Sixty-seven patients (69.8%) classified as type II or III (group 2) underwent an extended gastrectomy. We compared the patients of both groups retrospectively for disease-free survival and postoperative complications. The general performance status of most patients was comparable in both groups and was assigned to the American Society of Anesthesiologists class II or III. Statistically significant differences between the groups were seen for the postoperative reintubation rate [group 1: 31.0% vs. group 2: 9.0% (P = 0.009)], median time for surgery [group 1: 6 (3.5-8.5) hours vs. group 2: 4.7 (2.2-11.5) hours (P = 0.001)], time in the intensive care unit [group 1: 6 (3-85) days vs. group 2: 3 (1-54) days (P = 0.001)], median hospitalization time [group 1: 23 (14-105) days vs. group 2: 18 (10-63) days (P = 0.018)]. No statistical difference was observed for the recurrence-free survival of 40% after 3 years (P = 0.311), the mortality rate, the morbidity rate (P = 0.108), surgical and respiratory complications, and the incidence of anastomotic leakage (P = 0.645). We conclude that in selected cases it may be possible to perform an extended gastrectomy for small type I cancers.",
keywords = "Humans, Middle Aged, Treatment Outcome, Length of Stay, Survival Rate, Follow-Up Studies, Time Factors, Disease-Free Survival, Cause of Death, Retrospective Studies, Intensive Care, Postoperative Complications, Anastomosis, Surgical adverse effects, Lymph Node Excision, Anastomosis, Roux-en-Y methods, Esophageal Neoplasms surgery, Esophagectomy methods, Esophagogastric Junction surgery, Esophagus surgery, Gastrectomy methods, Hospitalization, Intubation, Intratracheal, Jejunum surgery, Pneumonia etiology, Positive-Pressure Respiration, Respiratory Insufficiency etiology, Stomach Neoplasms surgery, Humans, Middle Aged, Treatment Outcome, Length of Stay, Survival Rate, Follow-Up Studies, Time Factors, Disease-Free Survival, Cause of Death, Retrospective Studies, Intensive Care, Postoperative Complications, Anastomosis, Surgical adverse effects, Lymph Node Excision, Anastomosis, Roux-en-Y methods, Esophageal Neoplasms surgery, Esophagectomy methods, Esophagogastric Junction surgery, Esophagus surgery, Gastrectomy methods, Hospitalization, Intubation, Intratracheal, Jejunum surgery, Pneumonia etiology, Positive-Pressure Respiration, Respiratory Insufficiency etiology, Stomach Neoplasms surgery",
author = "G Schumacher and Schmidt, {S C} and N Schlechtweg and Thomas R{\"o}sch and M Sacchi and {von Dossow}, V and Chopra, {S S} and J Pratschke and J Zhukova and J Stieler and P Thuss-Patience and P Neuhaus",
year = "2009",
language = "Deutsch",
volume = "22",
pages = "422--426",
journal = "DIS ESOPHAGUS",
issn = "1120-8694",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction.

AU - Schumacher, G

AU - Schmidt, S C

AU - Schlechtweg, N

AU - Rösch, Thomas

AU - Sacchi, M

AU - von Dossow, V

AU - Chopra, S S

AU - Pratschke, J

AU - Zhukova, J

AU - Stieler, J

AU - Thuss-Patience, P

AU - Neuhaus, P

PY - 2009

Y1 - 2009

N2 - Precise classification of cancers of the esophagogastric junction according to Siewert may be difficult for the presence of Barrett's esophagus or hiatal hernia, which subsequently leads to a difficult choice of the surgical procedure of esophagectomy or gastrectomy. Ninety-six patients with such cancers were operated on in our department in 7 years. Twenty-nine patients (30.2%), classified as type I (group 1), underwent a transthoracic esophagectomy with gastric pull up. Sixty-seven patients (69.8%) classified as type II or III (group 2) underwent an extended gastrectomy. We compared the patients of both groups retrospectively for disease-free survival and postoperative complications. The general performance status of most patients was comparable in both groups and was assigned to the American Society of Anesthesiologists class II or III. Statistically significant differences between the groups were seen for the postoperative reintubation rate [group 1: 31.0% vs. group 2: 9.0% (P = 0.009)], median time for surgery [group 1: 6 (3.5-8.5) hours vs. group 2: 4.7 (2.2-11.5) hours (P = 0.001)], time in the intensive care unit [group 1: 6 (3-85) days vs. group 2: 3 (1-54) days (P = 0.001)], median hospitalization time [group 1: 23 (14-105) days vs. group 2: 18 (10-63) days (P = 0.018)]. No statistical difference was observed for the recurrence-free survival of 40% after 3 years (P = 0.311), the mortality rate, the morbidity rate (P = 0.108), surgical and respiratory complications, and the incidence of anastomotic leakage (P = 0.645). We conclude that in selected cases it may be possible to perform an extended gastrectomy for small type I cancers.

AB - Precise classification of cancers of the esophagogastric junction according to Siewert may be difficult for the presence of Barrett's esophagus or hiatal hernia, which subsequently leads to a difficult choice of the surgical procedure of esophagectomy or gastrectomy. Ninety-six patients with such cancers were operated on in our department in 7 years. Twenty-nine patients (30.2%), classified as type I (group 1), underwent a transthoracic esophagectomy with gastric pull up. Sixty-seven patients (69.8%) classified as type II or III (group 2) underwent an extended gastrectomy. We compared the patients of both groups retrospectively for disease-free survival and postoperative complications. The general performance status of most patients was comparable in both groups and was assigned to the American Society of Anesthesiologists class II or III. Statistically significant differences between the groups were seen for the postoperative reintubation rate [group 1: 31.0% vs. group 2: 9.0% (P = 0.009)], median time for surgery [group 1: 6 (3.5-8.5) hours vs. group 2: 4.7 (2.2-11.5) hours (P = 0.001)], time in the intensive care unit [group 1: 6 (3-85) days vs. group 2: 3 (1-54) days (P = 0.001)], median hospitalization time [group 1: 23 (14-105) days vs. group 2: 18 (10-63) days (P = 0.018)]. No statistical difference was observed for the recurrence-free survival of 40% after 3 years (P = 0.311), the mortality rate, the morbidity rate (P = 0.108), surgical and respiratory complications, and the incidence of anastomotic leakage (P = 0.645). We conclude that in selected cases it may be possible to perform an extended gastrectomy for small type I cancers.

KW - Humans

KW - Middle Aged

KW - Treatment Outcome

KW - Length of Stay

KW - Survival Rate

KW - Follow-Up Studies

KW - Time Factors

KW - Disease-Free Survival

KW - Cause of Death

KW - Retrospective Studies

KW - Intensive Care

KW - Postoperative Complications

KW - Anastomosis, Surgical adverse effects

KW - Lymph Node Excision

KW - Anastomosis, Roux-en-Y methods

KW - Esophageal Neoplasms surgery

KW - Esophagectomy methods

KW - Esophagogastric Junction surgery

KW - Esophagus surgery

KW - Gastrectomy methods

KW - Hospitalization

KW - Intubation, Intratracheal

KW - Jejunum surgery

KW - Pneumonia etiology

KW - Positive-Pressure Respiration

KW - Respiratory Insufficiency etiology

KW - Stomach Neoplasms surgery

KW - Humans

KW - Middle Aged

KW - Treatment Outcome

KW - Length of Stay

KW - Survival Rate

KW - Follow-Up Studies

KW - Time Factors

KW - Disease-Free Survival

KW - Cause of Death

KW - Retrospective Studies

KW - Intensive Care

KW - Postoperative Complications

KW - Anastomosis, Surgical adverse effects

KW - Lymph Node Excision

KW - Anastomosis, Roux-en-Y methods

KW - Esophageal Neoplasms surgery

KW - Esophagectomy methods

KW - Esophagogastric Junction surgery

KW - Esophagus surgery

KW - Gastrectomy methods

KW - Hospitalization

KW - Intubation, Intratracheal

KW - Jejunum surgery

KW - Pneumonia etiology

KW - Positive-Pressure Respiration

KW - Respiratory Insufficiency etiology

KW - Stomach Neoplasms surgery

M3 - SCORING: Zeitschriftenaufsatz

VL - 22

SP - 422

EP - 426

JO - DIS ESOPHAGUS

JF - DIS ESOPHAGUS

SN - 1120-8694

IS - 5

M1 - 5

ER -